Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Can Idea Group Amtd Stock Beat Estimates Price At 0.99 Up 0.82 20260406 Is Fifth Fitbo Stock Moving Sideways Price At 19.08 Up 0.37 20260406 Is Cingulate Cing Stock Moving Higher Price At 6.20 Up 0.98 20260406 Australia Courts Landmark Discrimination Ruling Against Giggle App May Set Precedent for Tech Firms Musk vs Altman Trial Reveals Tech Industrys Dark Underbelly Key Takeaways Descartes DSGX Q1 2026 Earnings Surprise EPS 052 Up Significant Ethereum Price Why ETH Is the Only Top10 Crypto Down This Week LendingTree TREE Q1 2026 Earnings Beat Revenue NA EPS 198 Vertiv VRT Stalls at 36856 Consolidation Phase 20260514 EU Negotiators Strike Deal on Key Clauses of US Trade Agreement Implementation Timing Remains Sticking Point Inovio Pharmaceuticals INO Stock Analysis Falls 112 Watching 125 20260514 New York Food Price Surge Raises Concerns Over Public Programme Expansion India Diversifies Crude Oil Sourcing with Increased Reliance on Russia Brazil and Venezuela Wall Street Week Ahead Soaring Stocks May Face Turbulence as Earnings Season Winds Down and Bond Yields Rise Micron Signals Sustained AI Demand as Singapore Investment Expands Professional Title Krispy Kremes 16 Million Data Breach Settlement Deadline Approaches Who May Qualify Barclays Raises Energy Transfer Price Target Suggests Stock May Be Undervalued Nextpower Inc NXT Q1 2026 Earnings EPS Surges Past Estimates Shares Advance Lufax Holding Q3 2024 Earnings Staggering EPS Miss Sends Shares Lower Inuvo Inc INUV Q1 2026 Earnings Massive EPS Beat Erases Loss Expectations Community West Bancshares CWBC Q1 2026 Earnings EPS Beat Drives Positive Stock Reaction AERT Q1 2026 Earnings EPS Breaks into Positive Territory Stock Rallies IMMP Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Phase BUUU Group Limited BUUU Faces Selling Pressure Down 211 in Recent Session Childrens Place PLCE Inches Higher as Stock Tests Key Resistance Near 357 Sagimet Biosciences SGMT Edges Higher as Clinical Momentum Builds SMX Security Matters Stock Plunges Nearly 10 as Selling Pressure Intensifies NHPAP Holds Steady Near Resistance Preferred Shares Edge Higher